DEPARTMENT OF HEALTH
Newborn Screening and Follow-Up Program; Addition of a Disorder to the Mandatory Screening Panel
[49 Pa.B. 556]
[Saturday, February 2, 2019]
Under section 3(d) of the Newborn Child Testing Act (act) (35 P.S. § 623(d)), the Department of Health (Department), with the approval of the Newborn Screening and Follow-up Technical Advisory Board (Board), has the authority to establish by periodic publication in the Pennsylvania Bulletin changes to the lists under sections 3(a)(1) and (2) of the act those diseases for which newborn children shall be screened, laboratory screening results reported and follow-up services conducted.
The Department gives notice that, as recommended and approved by the Board on September 20, 2018, spinal muscular atrophy will be added to the mandatory screening panel, set forth in section 3(a)(1) of the act, effective March 1, 2019.
For additional information contact Stacey Gustin, Program Manager, Division of Newborn Screening and Genetics, (717) 783-8143. Speech and/or hearing-impaired persons use V/TT (717) 783-6514 or the Pennsylvania AT&T Relay Service at (800) 654-5984 (TT).
RACHEL L. LEVINE, MD,
[Pa.B. Doc. No. 19-153. Filed for public inspection February 1, 2019, 9:00 a.m.]
No part of the information on this site may be reproduced for profit or sold for profit.
This material has been drawn directly from the official Pennsylvania Bulletin full text database. Due to the limitations of HTML or differences in display capabilities of different browsers, this version may differ slightly from the official printed version.